Back to Search
PATRICK HWU, M.D.
M.D.
Medical Oncology Physician
NPI: 1407949944Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
ME147873(FL)L9741(TX)
Research & Publications (20)
Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib.
PMID 19213663·Clin Genitourin Cancer·2009
8-other
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
PMID 19521262·Melanoma Res·2009
3-trial
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy.
PMID 19200815·Vaccine·2009
7-preclinical
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
PMID 19506454·Am J Clin Oncol·2009
3-trial
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.
PMID 19671763·Mol Cancer Ther·2009
8-other
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
PMID 19430405·Melanoma Res·2009
3-trial
Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival.
PMID 19541791·Ann Oncol·2009
8-other
Summary of the primer on tumor immunology and the biological therapy of cancer.
PMID 19175928·J Transl Med·2009
8-other
IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity.
PMID 19494262·J Immunol·2009
7-preclinical
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
PMID 19002462·Cancer Chemother Pharmacol·2009
3-trial
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
PMID 19440934·Cancer Invest·2009
3-trial
Biochemotherapy in patients with advanced head and neck mucosal melanoma.
PMID 18798304·Head Neck·2008
8-other
Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.
PMID 18832570·Am J Pathol·2008
8-other
Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer.
PMID 18794521·Proc Natl Acad Sci U S A·2008
7-preclinical
Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.
PMID 18259609·J Clin Invest·2008
7-preclinical
Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.
PMID 18509745·J Inherit Metab Dis·2008
6-review
Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
PMID 18569391·J Immunotoxicol·2008
4-observational
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.
PMID 18584354·Cancer Invest·2008
8-other
Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment.
PMID 18626307·Melanoma Res·2008
3-trial
Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.
PMID 18936790·Nat Clin Pract Oncol·2008
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR
TAMPA, FL 33612 - Phone
- (813) 745-4673
Quick Facts
- NPI
- 1407949944
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile